Search Results - "Erill, N"

Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry by Gallego, Oscar, Cuatrecasas, M., Benavides, M., Segura, P. P., Berrocal, A., Erill, N., Colomer, A., Quintana, M. J., Balaña, C., Gil, M., Gallardo, A., Murata, P., Barnadas, A.

“…Epidermal growth factor receptor gene ( EGFR ) alteration is a common feature in most of glioblastoma multiforme (GBM). Robust response of anti-EGFR treatments…”
Get full text

MC13-0065 Quantitative assessment of VEGF, BCL6 and CMYC predicts outcome in patients with DLBCL treated with R-CHOP: Implications for guiding future treatment selection by Donovan, M, Erill, N, Puig, P, Colomer, A, Colomo, L, Campo, E

Get full text

MC13-0051 Molecular characterization of anaplastic astrocytoma and glioblastoma multiforme: PTEN loss in conjunction with EGFR alterations predicts response to therapy by Donovan, M, Colomer, A, Puig, P, Erill, N, Alarcon, I, Vidal, N, Ferrer, I

Get full text

Erratum to: Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry by Gallego, Oscar, Cuatrecasas, M., Benavides, M., Segura, P. P., Berrocal, A., Erill, N., Colomer, A., Quintana, M. J., Balaña, C., Gil, M., Gallardo, A., Murata, P., Barnadas, A.

Get full text

Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses by Villanueva, A, Reyes, G, Cuatrecasas, M, Martinez, A, Erill, N, Lerma, E, Farre, A, Lluis, F, Capella, G

“…BACKGROUND & AIMS: Mutations at codon 12 of the K-ras gene are present in 65%-100% of carcinomas of human exocrine pancreas and could be used as a potential…”
Get full text

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy by Valera, Alexandra, López-Guillermo, Armando, Cardesa-Salzmann, Teresa, Climent, Fina, González-Barca, Eva, Mercadal, Santiago, Espinosa, Iñigo, Novelli, Silvana, Briones, Javier, Mate, José L, Salamero, Olga, Sancho, Juan M, Arenillas, Leonor, Serrano, Sergi, Erill, Nadina, Martínez, Daniel, Castillo, Paola, Rovira, Jordina, Martínez, Antonio, Campo, Elias, Colomo, Luis

“…MYC alterations influence the survival of patients with diffuse large B-cell lymphoma. Most studies have focused on MYC translocations but there is little…”
Get full text

Importance of 5569G/A polymorphism in intron 4 of HFE gene in the diagnosis of hereditary hemochromatosis by Román, R, Colomer, A, Erill, N, Puig, X, Guix, M

“…The presence of the 5569A polymorphism may lead to misdiagnosis of patients susceptible of hereditary hemochromatosis (HH). For that reason, samples containing…”
Get more information

K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines by Erill, N, Cuatrecasas, M, Sancho, FJ, Farre, A, Pour, PM, Lluis, F, Capella, G

“…K-ras and p53 gene alterations are frequently found in human pancreatic carcinomas and cell lines. The aim of this study was to analyze for the presence of…”
Get full text

Biochemical analysis and optimization of inhibition and adsorption phenomena in glass–silicon PCR-chips by Erill, Ivan, Campoy, Susana, Erill, Nadina, Barbé, Jordi, Aguiló, Jordi

“…The use of glass–silicon chips for PCR analysis has been widely reported in the last decade, but there have been few systematic efforts to pin down the…”
Get full text

Employing multiplex immunofluorescence to quantify Her2 and phosphorylated Her2 in formalin-fixed, paraffin-embedded breast tumor specimens by Donovan, MJ, Puig, P, Erill, N, Clayton, M, Hamann, S, Khan, F, Powell, D, Costa, J, Cordon-Cardo, C, Baselga, J

Get full text

K-ras mutations in nonmucinous ovarian epithelial tumors: A molecular analysis and clinicopathologic study of 144 patients by CUATRECASAS, M, ERILL, N, MUSULEN, E, COSTA, I, MATIAS-GUIU, X, PRAT, J

“…To assess the putative prognostic value of K-ras mutations in nonmucinous ovarian tumors, the authors looked for K-ras point mutations at codons 12 and 13 in…”
Get full text

Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression by Erill, Nadina, Colomer, Anna, Verdú, Montserrat, Román, Ruth, Condom, Enric, Hannaoui, Naim, Banús, Josep M, Cordon-Cardo, Carlos, Puig, Xavier

“…Altered p53 status is a frequent event in bladder cancer and reported to have prognostic significance. We studied the TP53 gene and its product in 76 patients…”
Get more information

A novel logistic model based on clinicopathological features predicts microsatellite instability in colorectal carcinomas by Colomer, Anna, Erill, Nadina, Vidal, August, Calvo, Miquel, Roman, Ruth, Verdú, Montse, Cordon-Cardo, Carlos, Puig, Xavier

“…High-frequency microsatellite instability has been reported to be associated with good prognosis in colorectal adenocarcinoma. However, methods to assess…”
Get more information

A Novel Multiplexing, Polymerase Chain Reaction-Based Assay for the Analysis of Chromosome 18q Status in Colorectal Cancer by Erill, Nadina, Colomer, Anna, Calvo, Miquel, Vidal, August, Román, Ruth, Verdú, Montse, Cordón-Cardó, Carlos, Puig, Xavier

“…Chromosome 18q allelic loss has been reported to have prognostic significance in stage II colorectal carcinoma. We have developed a fluorescent multiplex…”
Get full text

Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas by Colomer, Anna, Erill, Nadina, Verdú, Montse, Roman, Ruth, Vidal, August, Cordon-Cardo, Carlos, Puig, Xavier

“…Multiple studies using primary tumors have reported that alterations in p53 expression and detection of TP53 mutations are associated with clinical…”
Get full text